Helena Leijon
- Nephrology top 5%
-
- Lung Cancer Research Studies 5
-
- Neuroblastoma Research and Treatments 6
-
- Pituitary Gland Disorders and Treatments 5
- Hormonal Regulation and Hypertension 4
-
- Neuroendocrine Tumor Research Advances 8
-
- Adrenal and Paraganglionic Tumors 7
-
- Genetic Syndromes and Imprinting 3
-
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Caj HaglundJohanna ArolaTiina VesterinenSatu Maria RemesCamilla Schalin‐JänttiEeva RyhänenJohanna LouhimoIlkka Heiskanen
- Cited by
- NephrologyOncologyNeurology
- Journals
- The Journal of Clinical Endocrinology & Metabolism (2 papers)International Journal of Molecular Sciences (1 paper)Journal of Histochemistry & Cytochemistry (1 paper)
- Partner nations
- FinlandUnited StatesGermany
In The Last Decade
Helena Leijon
18 papers receiving 279 citations
Peers
Comparison fields: 5 of 45
- Nephrology 91
- Oncology 137
- Neurology 66
- Endocrinology, Diabetes and Metabolism 60
- Epidemiology 113
Countries citing papers authored by Helena Leijon
This map shows the geographic impact of Helena Leijon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Leijon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Leijon more than expected).
Fields of papers citing papers by Helena Leijon
This network shows the impact of papers produced by Helena Leijon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Leijon. The network helps show where Helena Leijon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Helena Leijon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 10 | |
| 8 | 2021 | 19 | |
| 9 | 2021 | 9 | |
| 10 | 2020 | 4 | |
| 11 | 2019 | 31 | |
| 12 | 2019 | 13 | |
| 13 | 2019 | 22 | |
| 14 | 2018 | 38 | |
| 15 | 2017 | 14 | |
| 16 | 2017 | 12 | |
| 17 | 2017 | 80 | |
| 18 | 2016 | 6 | |
| 19 | [Pheochromocytoma can be an insidious disease]. | 2013 | 0 |
About Helena Leijon
Helena Leijon is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Neurology, having authored 19 papers that have together received 283 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (8 papers), Adrenal and Paraganglionic Tumors (7 papers), Neuroblastoma Research and Treatments (6 papers), Pituitary Gland Disorders and Treatments (5 papers), Lung Cancer Research Studies (5 papers), Hormonal Regulation and Hypertension (4 papers), Genetic Syndromes and Imprinting (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Nephrology (91 citations), Oncology (137 citations) and Neurology (66 citations). Helena Leijon has collaborated with scholars based in Finland, United States and Germany. Frequent co-authors include Caj Haglund, Johanna Arola, Tiina Vesterinen, Satu Maria Remes, Camilla Schalin‐Jäntti, Johanna Arola, Eeva Ryhänen, Johanna Louhimo, Ilkka Heiskanen and Markku Miettinen. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, International Journal of Molecular Sciences and Journal of Histochemistry & Cytochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.